A major breakthrough in cancer study is occurring with the use of VHH fragments to restore dysfunctional p53. This vital cancer inhibitor protein is frequently inactivated in various kinds of malignancies, leading https://agency-social.com/story7004301/mini-antibodies-reactivate-the-p53-protein-the-potential-pathway-for-tumor-therapy